Veeva MedTech Clinical Trials Report Signals Significant Opportunity to Improve Data Delivery and Quality
(Adnkronos) – 83% use email, portals, and paper to exchange information with study partners, slowing study execution and increasing risk of non-compliance BARCELONA, Spain, April 19, 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV)
